Clinical Trial Update: Trial of Exenatide for Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating exenatide for Parkinson's disease has completed, according to the trial record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: University College, London | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED